Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131MIBG Treatment of Malignant Pheochromocytoma
NCT00028106Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Iobenguane I-131 in pheochromocytoma, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Dec 2001; status: completed.
02
Drugs
Iobenguane I-131
03
Conditions
pheochromocytoma
Beyond the preview
Go deeper on NCT00028106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028106.